Kronos Bio, Inc. (NASDAQ:KRON – Get Free Report) CEO Norbert W. Bischofberger acquired 1,378,901 shares of the business’s stock in a transaction that occurred on Monday, June 10th. The shares were acquired at an average cost of $0.88 per share, with a total value of $1,213,432.88. Following the transaction, the chief executive officer now directly […]
Kronos Bio, Inc. (NASDAQ:KRON – Get Free Report) was the target of a large drop in short interest in January. As of January 31st, there was short interest totalling 597,700 shares, a drop of 74.9% from the January 15th total of 2,380,000 shares. Currently, 1.6% of the shares of the stock are sold short. Based […]
Kronos Bio (NASDAQ:KRON – Free Report) had its price target cut by HC Wainwright from $9.00 to $2.50 in a research report sent to investors on Tuesday, Benzinga reports. They currently have a buy rating on the stock. Separately, Piper Sandler dropped their price objective on Kronos Bio from $7.00 to $6.00 and set an […]
Kronos Bio, Inc. (NASDAQ:KRON) Shares Sold by Coastal Bridge Advisors LLC etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.